Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2017

  • ID: 4315789
  • Report
  • 79 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Brain Biosciences Inc
  • GE Healthcare LLC
  • Jagiellonian University
  • Philips Healthcare
  • Ray Vision Intl Corp.
  • Stanford University
  • MORE
Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2017

Summary

The analyst's Medical Devices sector report, “Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2017" provides an overview of Positron Emission Tomography (PET) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Positron Emission Tomography (PET) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Positron Emission Tomography (PET) Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Brain Biosciences Inc
  • GE Healthcare LLC
  • Jagiellonian University
  • Philips Healthcare
  • Ray Vision Intl Corp.
  • Stanford University
  • MORE
1 Table of Contents
2 Introduction
2.1 Positron Emission Tomography (PET) Systems Overview
3 Products under Development
3.1 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
3.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
3.3 Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
3.4 Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
4 Positron Emission Tomography (PET) Systems - Pipeline Products under Development by Companies
4.1 Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
4.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
5 Positron Emission Tomography (PET) Systems Companies and Product Overview
5.1 Brain Biosciences Inc Company Overview
5.1.1 Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 GE Healthcare LLC Company Overview
5.2.1 GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 General De Equipment for Medical Imaging SA Company Overview
5.3.1 General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview
5.4 Jagiellonian University Company Overview
5.4.1 Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview
5.5 Philips Healthcare Company Overview
5.5.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
5.6 Ray Vision Intl Corp. Company Overview
5.6.1 Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Stanford University Company Overview
5.7.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.8 SynchroPET Company Overview
5.8.1 SynchroPET Pipeline Products & Ongoing Clinical Trials Overview
5.9 University of British Columbia Company Overview
5.9.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
5.10 University of Washington Company Overview
5.10.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview
5.11 West Virginia University Company Overview
5.11.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview
5.12 Zecotek Photonics Inc Company Overview
5.12.1 Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Positron Emission Tomography (PET) Systems- Recent Developments
6.1 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery
6.2 May 31, 2017: Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017
6.3 May 30, 2017: Zecotek Receives $100,000 Order for Patented LFS Scintillation Crystals from Major Chinese OEM
6.4 May 25, 2017: Chinese OEMs Qualify LFS Scintillation Crystals for use in Positron Emission Tomography Medical Scanning Devices
6.5 May 25, 2017: Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors
6.6 May 15, 2017: Threshold Pharmaceuticals Reports First Quarter Financial Results
6.7 Apr 07, 2017: PET radiotracer design for monitoring targeted immunotherapy
6.8 Mar 27, 2017: Threshold Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results
6.9 Mar 23, 2017: Advanced Accelerator Applications Reports 23% Sales Growth for Fiscal 2016; Continued NETSPOT Launch Success
6.10 Mar 21, 2017: Zecotek Provides Update to Chinese PET OEM MOU
6.11 Mar 21, 2017: AMITA Health Offers Unique Opportunity For Medicare Recipients To Determine Whether They Have Alzheimer's
6.12 Mar 09, 2017: Shanghai EBO Optoelectronics Company to Exclusively use Zecotek LFS Scintillation Crystals in China
6.13 Feb 14, 2017: Care and convenience for patients with new PET scanner at St George Hospital
6.14 Feb 14, 2017: ADDvise receives order from Consto AS worth 2,9 MNOK
6.15 Jan 25, 2017: Zecotek Signs LFS Scintillation Crystal Supply Agreement Worth $21 million Over the Next 3 Years
6.16 Dec 08, 2016: Advanced Accelerator Applications Announces CMS Pass-Through Reimbursement Code for its First FDA Approved Drug NETSPOT
6.17 Dec 07, 2016: Progenics Pharmaceuticals Announces First Patient Dosed in Phase 2/3 Clinical Trial of PSMA-Targeted PET/CT Imaging Agent PyL
6.18 Nov 28, 2016: Advanced Accelerator Applications Reports 15.4% Sales Growth in the Third Quarter of 2016
6.19 Nov 15, 2016: Rocky Mountain Cancer Centers First In Region to Offer Newly Approved Gallium DOTATATE PET/CT for Neuroendocrine Tumors
6.20 Nov 07, 2016: Threshold Pharmaceuticals Reports Third Quarter Financial Results
6.21 Nov 02, 2016: Advanced Accelerator Applications Announces Swiss Marketing Authorization for Two PET Diagnostic Products
6.22 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation
6.23 Nov 01, 2016: Neuraceq Automated Synthesizer Synthera Received Shonin Approval in Japan
6.24 Oct 24, 2016: The Journal of Urology Publishes Blue Earth Diagnostics’ Phase 3 Study Results of Axumin for PET Imaging of Recurrent Prostate Cancer
6.25 Oct 13, 2016: Chinese OEM Orders Zecotek's LFS Scintillation Crystals for Third Scanner
6.26 Oct 08, 2016: Oncovision will develop a technology for the early diagnosis of Alzheimer’s disease
6.27 Oct 05, 2016: Mayo Clinic researchers map prostate cancer relapse using C-11 choline PET and MRI
6.28 Oct 04, 2016: Zecotek Announces Preliminary Revenue for Fiscal 2016
6.29 Oct 03, 2016: Jubilant DraxImage Receives FDA Approval for RUBY-FILL Rubidium 82 Generator and Elution System
6.30 Sep 26, 2016: FluoroPharma Announces CardioPET Phase II Results at the 21st American Society of Nuclear Cardiology (ASNC) Meeting
6.31 Sep 22, 2016: EMA Recommends Granting a Marketing Authorisation for Edotreotide
6.32 Sep 22, 2016: Lantheus to Present New Data at the ASNC Annual Scientific Session on the Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Patients with Suspected Heart Disease Undergoing Exercise Stress Testing
6.33 Sep 07, 2016: Bruker Unveils Next-Generation Preclinical Imaging Systems for Advanced Translational Research at World Molecular Imaging Congress
6.34 Aug 31, 2016: Advanced Accelerator Applications Reports 24.4% Sales Growth in the Second Quarter of 2016
6.35 Aug 03, 2016: Advanced Accelerator Applications Announces First Administration of NETSPOT™ at Holy Name Medical Center
6.36 Aug 01, 2016: Threshold Pharmaceuticals Reports Second Quarter Financial Results
6.37 Jul 28, 2016: Update on Chinese OEM Building PET Scanners
6.38 Jul 27, 2016: New Studies Suggest Relationship Between Tau Pathology And Progression Of Alzheimer's Disease
6.39 Jul 18, 2016: MabVax Therapeutics Initiates Patient Enrollment in a Phase I Trial for a New Diagnostic Imaging Product for Pancreatic Cancer
6.40 Jul 12, 2016: UCDavis Orders More LFS Crystals
6.41 Jul 12, 2016: Oncodesign Announces the Launch of Its First Clinical Study on a Radiotracer in Patients with Non-Small Cell Lung Cancer
6.42 Jul 08, 2016: New funding for the harmonisation and alignment of brain imaging methods
6.43 Jul 07, 2016: Two SwedishAmerican Physician Executives Assume New Positions
6.44 Jun 30, 2016: Zecotek receives second LFS Scintillation order for Radiation Safety and Homeland Security
6.45 Jun 24, 2016: Genome British Columbia Investing in Companies and Jobs Through e@UBC
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
Table 5: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
Table 6: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
Table 7: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 8: CerePET - Product Status
Table 9: CerePET - Product Description
Table 10: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 11: Q.Clear - Product Status
Table 12: Q.Clear - Product Description
Table 13: General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview
Table 14: CareMiBrain - Product Status
Table 15: CareMiBrain - Product Description
Table 16: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Positron Emission Tomography System - Product Status
Table 18: Positron Emission Tomography System - Product Description
Table 19: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Additional PET Scan - Product Status
Table 21: Additional PET Scan - Product Description
Table 22: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Helmet - PET System - Product Status
Table 24: Helmet - PET System - Product Description
Table 25: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Breast-Dedicated PET System - Product Status
Table 27: Breast-Dedicated PET System - Product Description
Table 28: Dual Panel PET Scanner - Product Status
Table 29: Dual Panel PET Scanner - Product Description
Table 30: Dual-isotope Positron Emitting Tomography System - Product Status
Table 31: Dual-isotope Positron Emitting Tomography System - Product Description
Table 32: MR Compatible PET System - Product Status
Table 33: MR Compatible PET System - Product Description
Table 34: PET Sensitivity Enhancing Device - Product Status
Table 35: PET Sensitivity Enhancing Device - Product Description
Table 36: PET System - Product Status
Table 37: PET System - Product Description
Table 38: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Breast PET-MRI - Product Status
Table 40: Breast PET-MRI - Product Description
Table 41: Wrist Scanner - Product Status
Table 42: Wrist Scanner - Product Description
Table 43: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
Table 44: PET Imaging Tool - Product Status
Table 45: PET Imaging Tool - Product Description
Table 46: University of Washington Pipeline Products & Ongoing Clinical Trials Overview
Table 47: DS-PS3 Positron Emission Tomography Detector - Product Status
Table 48: DS-PS3 Positron Emission Tomography Detector - Product Description
Table 49: High Resolution PET Detector - Product Status
Table 50: High Resolution PET Detector - Product Description
Table 51: PET-Mammogram-Biopsy System - Product Status
Table 52: PET-Mammogram-Biopsy System - Product Description
Table 53: West Virginia University Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Positron Emission Tomography (PET) Imager - Product Status
Table 55: Positron Emission Tomography (PET) Imager - Product Description
Table 56: Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: New Generation PET Scanning Device - Product Status
Table 58: New Generation PET Scanning Device - Product Description
Table 59: Glossary

List of Figures
Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
Figure 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
Figure 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Brain Biosciences Inc
  • GE Healthcare LLC
  • General De Equipment for Medical Imaging SA
  • Jagiellonian University
  • Philips Healthcare
  • Ray Vision Intl Corp.
  • Stanford University
  • SynchroPET
  • University of British Columbia
  • University of Washington
  • West Virginia University
  • Zecotek Photonics Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll